Similar articles

• Normal height and weight in a series of ambulant Duchenne muscular dystrophy patients using the 10 day on/10 day off prednisone regimen.

  ten Dam K, de Groot IJ, Noordam C, van Alfen N, Hendriks JC, Sie LT. ten Dam K, et al. Neuromuscul Disord. 2012 Jun;22(6):500-4. doi: 10.1016/j.nmd.2012.01.005. Epub 2012 Mar 4. Neuromuscul Disord. 2012. PMID: 22390890
• Prednisone for Duchenne muscular dystrophy.

  Dubowitz V. Dubowitz V. Lancet Neurol. 2005 May;4(5):264. doi: 10.1016/S1474-4422(05)70050-8. Lancet Neurol. 2005. PMID: 15847833 No abstract available.
• Randomized, blinded trial of weekend vs daily prednisone in Duchenne muscular dystrophy.

  Escolar DM, Hache LP, Clemens PR, Cnaan A, McDonald CM, Viswanathan V, Kornberg AJ, Bertorini TE, Nevo Y, Lotze T, Pestronk A, Ryan MM, Monasterio E, Day JW, Zimmerman A, Arrieta A, Henricson E, Mayhew J, Florence J, Hu F, Connolly AM. Escolar DM, et al. Neurology. 2011 Aug 2;77(5):444-52. doi: 10.1212/WNL.0b013e318227b164. Epub 2011 Jul 13. Neurology. 2011. PMID: 21753160 Free PMC article. Clinical Trial.
• Change in natural history of Duchenne muscular dystrophy with long-term corticosteroid treatment: implications for management.

  Moxley RT 3rd, Pandya S, Ciafaloni E, Fox DJ, Campbell K. Moxley RT 3rd, et al. J Child Neurol. 2010 Sep;25(9):1116-29. doi: 10.1177/0883073810371004. Epub 2010 Jun 25. J Child Neurol. 2010. PMID: 20581335 Review.
• Why taper prednisone in dermatology?

  Blair M. Blair M. JAAPA. 2001 Apr;14(4):72. JAAPA. 2001. PMID: 11521370 Review. No abstract available.